Conflict and climate drive record global hunger in 2024, UN says
Conflict and climate drive record global hunger in 2024, UN says
ROME - Acute food insecurity and child malnutrition rose for a sixth consecutive year in 2024, affecting more than 295 million people across 53 countries and territories, according to a UN report released on May 16.
That marked a 5 per cent increase on 2023 levels, with 22.6 per cent of populations in worst-hit regions experiencing crisis-level hunger or worse.
'The 2025 Global Report on Food Crises paints a staggering picture,' said Mr Rein Paulsen, director of Emergencies and Resilience at the UN Food and Agriculture Organisation (FAO).
'Conflict, weather extremes and economic shocks are the main drivers, and they often overlap,' he added.
Looking ahead, the UN warned of worsening conditions in 2025, citing the steepest projected drop in humanitarian food funding since the report's inception -– put at anywhere between 10 per cent and more than 45 per cent.
US President Donald Trump has led the way, largely shutting down the US Agency for International Development (USAid), which provides aid to the world's needy, cancelling more than 80 per cent of its humanitarian programmes.
'Millions of hungry people have lost, or will soon lose, the critical lifeline we provide,' warned Ms Cindy McCain, the head of the Rome-based World Food Programme.
Conflict was the leading cause of hunger, impacting nearly 140 million people across 20 countries in 2024, including areas facing 'catastrophic' levels of food insecurity in Gaza, South Sudan, Haiti and Mali. Sudan has confirmed famine conditions.
Economic shocks, such as inflation and currency devaluation, helped push 59.4 million people into food crises in 15 countries – nearly double the levels seen prior to the Covid-19 pandemic – including Syria and Yemen.
Extreme weather, particularly El Nino-induced droughts and floods, shunted 18 countries into crisis, affecting more than 96 million people, especially in Southern Africa, Southern Asia, and the Horn of Africa.
The number of people facing famine-like conditions more than doubled to 1.9 million – the highest since monitoring for the global report began in 2016.
Malnutrition among children reached alarming levels, the report said.
Nearly 38 million children under five were acutely malnourished across 26 nutrition crises, including in Sudan, Yemen, Mali and Gaza.
Forced displacement also exacerbated hunger.
Nearly 95 million forcibly displaced people, including refugees and internally displaced persons, lived in countries facing food crises, such as Democratic Republic of Congo, Colombia.
Despite the grim overall trend, 2024 saw some progress.
In 15 countries, including Ukraine, Kenya and Guatemala, food insecurity eased due to humanitarian aid, improved harvests, easing inflation and a decline in conflict.
To break the cycle of hunger, the report called for investment in local food systems. "Evidence shows that supporting local agriculture can help the most people, with dignity, at lower cost," Mr Paulsen said. REUTERS
Find out more about climate change and how it could affect you on the ST microsite here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
14 hours ago
- Straits Times
Covid-19 shots for kids still recommended by US paediatric group in break with CDC
Sign up now: Get ST's newsletters delivered to your inbox The group said it recommends the Covid-19 shot for children ages 6 to 23 months. WASHINGTON – The American Academy of Paediatrics updated its recommendations for immunisations on Aug 19, including calling for Covid-19 shots for healthy kids, diverging from controversial advice from the federal government. The group said it recommends the Covid-19 shot for children ages 6 to 23 months. Earlier in 2025, Health and Human Services Secretary Robert F. Kennedy Jr changed advice that had been in place since the pandemic, saying healthy kids and pregnant women should not receive the vaccine. AAP has released its own recommendations since the 1930s. The group broke from the US Centres for Disease Control and Prevention in 2025 after Mr Kennedy replaced the members of an influential vaccine panel with people who have spread misinformation around vaccines. The revamped Advisory Committee on Immunisation Practices – or Acip – said it would reevaluate the childhood immunisation schedule at a meeting in June. Mr Kennedy's moves around vaccines have raised concern among public health experts, who have warned lifesaving shots could become harder to access. In response, medical groups have taken additional steps to publicise their vaccine guidelines and have urged insurers to cover shots they recommend. 'The AAP will continue to provide recommendations for immunisations that are rooted in science and are in the best interest of the health of infants, children and adolescents,' AAP President Susan Kressly said in a statement. HHS spokesman Andrew Nixon said in response to the new schedule that the group 'is undermining national immunisation policymaking with baseless political attacks.' He added it should remove 'conflict-of-interest safeguards and keep its publications free from financial influence,' without further elaborating. AAP said it had no conflicts of interest and has been making vaccine recommendations longer than Acip has existed. In May, the CDC updated its website to say healthy children 'may receive Covid-19 vaccination, informed by the clinical judgment of a health-care provider.' Previously, it recommended everyone 6 months or older get vaccinated. In its schedule, AAP also removed a hepatitis vaccine that is no longer available, and recommended children under 8 months old receive the RSV vaccine. It called for influenza shots for children as young as 6 months ahead of the flu season. Kids between 9 and 12 years old should receive the human papillomavirus vaccine, up from the previous recommendation of a starting dose at 11 years, according to the new guidelines. The changes in vaccination schedules comes as confusion mounts for parents. Acip decides which shots will be covered by insurance companies or federally funded through the Vaccines for Children Programme. By breaking with Acip, questions remain on which shots will be covered by insurance or readily available in clinics. 'The AAP urges every insurer to cover all the vaccines that are included in this immunisation schedule,' Ms Kressly said. A new group formed after Mr Kennedy revamped Acip is also trying to guide which shots are recommended. The Vaccine Integrity Project, led by University of Minnesota researchers and public health officials, gathered existing data on vaccines for Covid-19, RSV and flu shots and presented their findings on Aug 19 to professional societies, such as AAP, to help the organisations to develop their schedules. There are limitations in the data that the researchers were able to analyse. The Vaccine Integrity Project wasn't able to look at unpublished vaccine trial data or ongoing trials, and only analysed data presented to Acip in the past or peer reviewed, published literature. The group found no safety concerns over pregnant women taking the Covid-19 vaccine and that the shot was effective in preventing hospitalisations for children. Dr Jake Scott, an infectious disease specialist at Stanford University, said the group's work is ongoing. BLOOMBERG
Asia News Network
a day ago
- Asia News Network
Nepal eliminates rubella, highly contagious viral disease: WHO
August 19, 2025 KATHMANDU – Nepal has eliminated rubella, a highly contagious viral disease as a public health problem, the World Health Organisation, announced on Monday. The UN health body in its statement said that it is a remarkable achievement for a country making concerted efforts to protect its people from vaccine preventable diseases. Rubella, or German measles, is a highly contagious viral infection. It is serious particularly for pregnant women as infection can lead to miscarriage, stillbirth, or a range of lifelong and debilitating birth defects. But rubella is preventable with safe and cost-effective vaccines. 'Nepal's success reflects the unwavering commitment of its leadership, persistent efforts of the health care workers and volunteers, and unstinting support of engaged and informed communities, for a healthy start for babies and a future free of rubella disease,' said Dr Catharina Boehme, officer-in-charge WHO South-East Asia, while endorsing the recommendation of the Regional Verification Commission for Measles and Rubella elimination in South-East Asia Region (SEA-RVC) for Nepal to be verified for eliminating rubella. The SEA-RVC which held its annual meeting from July 22-24, 2025, reviewed and evaluated information and data submitted by the national verification committee on measles and rubella disease surveillance and immunisation coverage rates, and recommended verification of rubella elimination in Nepal. Nepal is the sixth country in WHO South-East Asia to achieve rubella elimination. Prioritising elimination of measles and rubella as public health problems in WHO South-East Asia by 2026, Bhutan, DPR Korea, Maldives, and Timor-Leste have eliminated measles, and Bhutan, DPR Korea, Maldives, Sri Lanka, Timor- Leste, and now Nepal have eliminated rubella. 'Congratulations to Nepal for eliminating rubella. This public health achievement is the result of close collaboration between the government, dedicated health workers, partners and communities,' said Dr Rajesh Sambhajirao Pandav, WHO Representative to Nepal. 'WHO is proud to have contributed to this journey and remains committed to supporting Nepal sustain this accomplishment.' Nepal introduced rubella-containing vaccine in its immunisation programme in 2012 with a nationwide campaign for the age group 9 months to 15 years. A second dose of rubella-containing vaccine was added to the routine immunisation schedule in 2016. Four national campaigns with rubella vaccines in 2012, 2016, 2020, and 2024, helped increase access, despite major public health emergencies such as the COVID-19 pandemic and earthquakes in 2015 and 2023. By 2024, Nepal achieved over 95 percent coverage for at least one dose of rubella vaccine. Innovative strategies such as observing 'immunisation month', outreach to vaccinate missed children, and motivation for the districts to be declared 'fully immunised', provided further impetus to elimination efforts. To further strengthen surveillance, Nepal recently introduced a robust laboratory testing algorithm, the first in the WHO South-East Asia Region to do so.
Business Times
2 days ago
- Business Times
Australian biotech giant CSL to spin off vaccine unit Seqirus, cut 15% of workforce
[SYDNEY] Australian biotech giant CSL said that it will spin off its Seqirus vaccine business into a separately listed company as part of a restructure that will see it reduce its workforce by as much as 15 per cent and cut costs by around US$500 million a year. CSL Seqirus, which makes seasonal influenza vaccines, contributed US$2.2 billion of the firm's total revenue of US$15.6 billion in the 12 months ended Jun 30, the Melbourne-based company said on Tuesday (Aug 19). Net profit rose 17 per cent to US$3 billion, just above analyst estimates of US$2.97 billion. Seqirus will list on the Australian securities exchange by the end of this fiscal year. The spinoff will give Seqirus, which will be chaired by Gordon Naylor, 'autonomy to set an independent strategic direction, including capitalising on potential opportunities that may arise in a highly dynamic vaccines market, as well as reducing complexity, making the business more agile and efficient to manage', CSL said. CSL also closed 22 underperforming US plasma centres this month, and will consolidate its research and development from 11 sites into six. The restructure will unlock US$500 million in annual savings by the end of fiscal 2028, though CSL will incur one-off restructuring costs of US$700 million to US$770 million. While CSL employs around 32,000 people, no firm number was put on the job cuts. Further details on the Seqirus spinoff will be given at CSL's capital markets day on Nov 4 to 6 in the US. CSL also plans to buy back A$750 million (S$626 million) of shares this financial year, the first step in a multi-year buyback. BLOOMBERG
